Covered recipient · General Payments record
NEVA K GULSBY
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2024
$2,664.19
- Reported across 160 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $582.83 | 33 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $259.32 | 14 |
| PFIZER INC. | $71.06 | 4 |
| Supernus Pharmaceuticals, Inc. | $70.70 | 4 |
| Novo Nordisk AS | $38.39 | 2 |
| Acerta Pharma LLC | $30.03 | 2 |
| Lilly USA, LLC | $29.87 | 2 |
| SANOFI-AVENTIS U.S. LLC | $21.77 | 1 |
| IRONWOOD PHARMACEUTICALS, INC | $16.82 | 1 |
| Astellas Pharma US Inc | $16.28 | 1 |
| Tris Pharma Inc | $15.25 | 1 |
| Ardelyx, Inc. | $13.34 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (33)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $3.17 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107264415 | CMS |
| ABBVIE INC. | $6.67 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107264417 | CMS |
| ABBVIE INC. | $17.30 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107264419 | CMS |
| ABBVIE INC. | $18.82 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107264421 | CMS |
| ABBVIE INC. | $20.02 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107264423 | CMS |
| ABBVIE INC. | $11.26 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107264425 | CMS |
| ABBVIE INC. | $18.77 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107264427 | CMS |
| ABBVIE INC. | $15.15 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107264429 | CMS |
| ABBVIE INC. | $13.30 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107264431 | CMS |
| ABBVIE INC. | $13.33 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107264433 | CMS |
| ABBVIE INC. | $5.02 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107264435 | CMS |
| ABBVIE INC. | $88.13 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107264437 | CMS |
| ABBVIE INC. | $20.27 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107264439 | CMS |
| ABBVIE INC. | $8.11 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107264441 | CMS |
| Ardelyx, Inc. | $13.34 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146728966 | CMS |
| Astellas Pharma US Inc | $16.28 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139521536 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.80 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104734493 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.23 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105451305 | CMS |
| IRONWOOD PHARMACEUTICALS, INC | $16.82 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153714909 | CMS |
| Lilly USA, LLC | $15.72 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135850682 | CMS |
| Lilly USA, LLC | $14.15 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135850686 | CMS |
| Novo Nordisk Inc | $14.58 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100595701 | CMS |
| Novo Nordisk Inc | $23.81 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100278168 | CMS |
| PFIZER INC. | $15.39 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131076701 | CMS |
| PFIZER INC. | $16.02 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131284068 | CMS |
| PFIZER INC. | $19.21 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132109923 | CMS |
| PFIZER INC. | $20.44 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131105686 | CMS |
| SANOFI-AVENTIS U.S. LLC | $21.77 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139904551 | CMS |
| Supernus Pharmaceuticals, Inc. | $15.48 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147849358 | CMS |
| Supernus Pharmaceuticals, Inc. | $16.02 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147849360 | CMS |
| Supernus Pharmaceuticals, Inc. | $17.19 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147807932 | CMS |
| Supernus Pharmaceuticals, Inc. | $22.01 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147807934 | CMS |
| Tris Pharma Inc | $15.25 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147239953 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.